LC
DMTK

Lindbrook Capital’s DermTech, Inc. Common Stock DMTK Stock Holding History

Lindbrook Capital’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-100
Closed -$70 – 2851
2024
Q1 		$70 Hold
100
– – ﹤0.01% 2618
2023
Q4 		$175 Hold
100
– – ﹤0.01% 2647
2023
Q3 		$144 Hold
100
– – ﹤0.01% 2645
2023
Q2 		$260 Hold
100
– – ﹤0.01% 2639
2023
Q1 		$368 Hold
100
– – ﹤0.01% 2660
2022
Q4 		$177 Hold
100
– – ﹤0.01% 2745
2022
Q3 		$0 Hold
100
– – ﹤0.01% 2975
2022
Q2 		$1K Hold
100
– – ﹤0.01% 2429
2022
Q1 		$1K Sell
100
-20
-17% -$268 ﹤0.01% 2426
2021
Q4 		$2K Sell
120
-30
-20% -$720 ﹤0.01% 1848
2021
Q3 		$5K Buy
150
+50
+50% +$1.76K ﹤0.01% 1276
2021
Q2 		$4K Hold
100
– – ﹤0.01% 1417
2021
Q1 		$5K Buy
+100
New +$5.23K ﹤0.01% 1288

Other funds holding DMTK

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
GWSA
Global Wealth Strategies & Associates Denver, Colorado $528M AUM 23.18% 1-Year Est. Return
T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $399M AUM 20.13% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return

Lindbrook Capital's DMTK Position: Q2 2024 in Review

Lindbrook Capital sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 100 shares — an estimated $70 sold.

Lindbrook Capital first reported a position in DMTK in Q1 2021 and held it in 13 quarters. The position peaked at $5K in Q3 2021. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • Lindbrook Capital reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Lindbrook Capital sold 100 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $70.
  • Lindbrook Capital first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 13 quarters.
  • Lindbrook Capital's DermTech, Inc. Common Stock position peaked at $5K in Q3 2021.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Lindbrook Capital's 13F filing for Q2 2024, filed 31 Jul 2024.